Medpace Holdings [MEDP] vs Danaher [DHR] Detailed Stock Comparison

Medpace Holdings

NASDAQ
Loading...

Danaher

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Medpace Holdings wins in 10 metrics, Danaher wins in 9 metrics, with 0 ties. Medpace Holdings appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricMedpace HoldingsDanaherBetter
P/E Ratio (TTM)39.5645.65Medpace Holdings
Price-to-Book Ratio86.572.94Danaher
Debt-to-Equity Ratio86.9335.45Danaher
PEG Ratio3.64-1.22Danaher
EV/EBITDA29.7422.54Danaher
Profit Margin (TTM)18.74%14.21%Medpace Holdings
Operating Margin (TTM)20.94%20.12%Medpace Holdings
EBITDA Margin (TTM)20.94%20.12%Medpace Holdings
Return on Equity89.39%6.68%Medpace Holdings
Return on Assets (TTM)17.09%4.01%Medpace Holdings
Free Cash Flow (TTM)$572.27M$5.30BDanaher
1-Year Return52.42%-21.68%Medpace Holdings
Price-to-Sales Ratio (TTM)6.706.41Danaher
Enterprise Value$15.06B$169.55BDanaher
EV/Revenue Ratio6.757.06Medpace Holdings
Gross Profit Margin (TTM)29.84%59.35%Danaher
Revenue per Share (TTM)$74$33Medpace Holdings
Earnings per Share (Diluted)$13.46$4.71Medpace Holdings
Beta (Stock Volatility)1.410.80Danaher
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Medpace Holdings vs Danaher Stock Performance Analysis

Loading Price Chart...

Medpace Holdings
Danaher
Medpace Holdings Stock Overview | Danaher Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medpace Holdings-0.41%5.90%7.76%66.29%82.80%58.42%
Danaher-1.53%13.79%6.59%6.05%17.21%-7.88%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medpace Holdings52.42%246.47%328.56%1,791.23%1,791.23%1,791.23%
Danaher-21.68%-5.87%4.99%254.15%651.28%1,113.24%

News Based Sentiment: Medpace Holdings vs Danaher

Medpace Holdings

News based Sentiment: MIXED

Medpace is showing strong financial performance with increased institutional investment and positive guidance, but faces a recent analyst downgrade and a relatively high valuation. The combination of positive and negative developments creates a mixed investment picture for the month.

View Medpace Holdings News Sentiment Analysis

Danaher

News based Sentiment: MIXED

Danaher delivered a mixed month, with strong Q2 results and positive developments in AI and potential tariff benefits offset by challenges in the Life Sciences segment and differing analyst opinions. The company's overall outlook remains positive, but investors should monitor key areas for potential risks and opportunities.

View Danaher News Sentiment Analysis

Performance & Financial Health Analysis: Medpace Holdings vs Danaher

MetricMEDPDHR
Market Information
Market Cap i$14.96B$153.94B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i278,9805,958,360
90 Day Avg. Volume i314,9434,345,910
Last Close$530.30$211.71
52 Week Range$250.05 - $547.15$171.00 - $279.41
% from 52W High-3.08%-24.23%
All-Time High$547.15 (Oct 01, 2025)$296.06 (Sep 06, 2021)
% from All-Time High-3.08%-28.49%
Growth Metrics
Quarterly Revenue Growth0.14%0.03%
Quarterly Earnings Growth0.02%-0.39%
Financial Health
Profit Margin (TTM) i0.19%0.14%
Operating Margin (TTM) i0.21%0.20%
Return on Equity (TTM) i0.89%0.07%
Debt to Equity (MRQ) i86.9335.45
Cash & Liquidity
Book Value per Share (MRQ)$6.15$73.10
Cash per Share (MRQ)$1.65$4.13
Operating Cash Flow (TTM) i$614.10M$6.17B
Levered Free Cash Flow (TTM) i$445.14M$3.88B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Medpace Holdings vs Danaher

MetricMEDPDHR
Price Ratios
P/E Ratio (TTM) i39.5645.65
Forward P/E i42.6325.66
PEG Ratio i3.64-1.22
Price to Sales (TTM) i6.706.41
Price to Book (MRQ) i86.572.94
Market Capitalization
Market Capitalization i$14.96B$153.94B
Enterprise Value i$15.06B$169.55B
Enterprise Value Metrics
Enterprise to Revenue i6.757.06
Enterprise to EBITDA i29.7422.54
Risk & Other Metrics
Beta i1.410.80
Book Value per Share (MRQ) i$6.15$73.10

Financial Statements Comparison: Medpace Holdings vs Danaher

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)MEDPDHR
Revenue/Sales i$558.57M$5.74B
Cost of Goods Sold i$380.22M$2.23B
Gross Profit i$178.35M$3.51B
Research & Development iN/A$379.00M
Operating Income (EBIT) i$113.52M$1.27B
EBITDA i$120.45M$1.87B
Pre-Tax Income i$118.17M$1.13B
Income Tax i$3.58M$175.00M
Net Income (Profit) i$114.60M$954.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)MEDPDHR
Cash & Equivalents i$441.44M$1.99B
Total Current Assets i$821.44M$9.53B
Total Current Liabilities i$1.12B$6.65B
Long-Term Debt i$126.66M$15.98B
Total Shareholders Equity i$593.61M$50.86B
Retained Earnings i$-269.72M$44.91B
Property, Plant & Equipment i$258.19MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)MEDPDHR
Operating Cash Flow i$166.55M$1.47B
Capital Expenditures i$-9.99M$-239.00M
Free Cash Flow i$115.84M$1.05B
Debt Repayment iN/AN/A
Common Stock Repurchase i$-371.90M$-1.08B

Short Interest & Institutional Ownership Analysis

MetricMEDPDHR
Shares Short i2.20M9.53M
Short Ratio i6.812.85
Short % of Float i0.10%0.01%
Average Daily Volume (10 Day) i278,9805,958,360
Average Daily Volume (90 Day) i314,9434,345,910
Shares Outstanding i30.63M719.10M
Float Shares i22.25M637.13M
% Held by Insiders i0.21%0.11%
% Held by Institutions i0.97%0.83%

Dividend Analysis & Yield Comparison: Medpace Holdings vs Danaher

MetricMEDPDHR
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A